Provided by Tiger Trade Technology Pte. Ltd.

Merck

101.09
+0.40000.40%
Post-market: 101.05-0.0400-0.04%19:59 EST
Volume:44.98M
Turnover:4.55B
Market Cap:250.91B
PE:13.38
High:102.20
Open:100.60
Low:100.11
Close:100.69
52wk High:105.84
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:3.09
T/O Rate:1.81%
Dividend:3.24
Dividend Rate:3.21%
EPS(TTM):7.56
EPS(LYR):6.76
ROE:39.49%
ROA:13.76%
PB:4.84
PE(LYR):14.95

Loading ...

HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating

MT Newswires Live
·
Dec 10

JPMorgan Chase, Merck Share Losses Lead Dow's Nearly 125-Point Drop

Dow Jones
·
Dec 10

EXCLUSIVE-US FDA launches fresh safety scrutiny of approved RSV therapies for infants

Reuters
·
Dec 09

Exclusive-U.S. FDA Officials Inform Merck, Sanofi and AstraZeneca Rsv Antibody Therapies Would Receive Fresh Safety Scrutiny -Sources Familiar With the Situation

THOMSON REUTERS
·
Dec 09

BRIEF-Saskatchewan Adds CAPVAXIVE To Publicly Funded Adult Immunization Program

Reuters
·
Dec 08

Saskatchewan Adds Capvaxive® to Publicly Funded Adult Immunization Program

THOMSON REUTERS
·
Dec 08

Trump signs memo to align US child vaccines with certain other countries

Reuters
·
Dec 06

Rpt-Trump: Cdc Vaccine Committee Made a Very Good Decision to End Their Hepatitis B Vaccine Recommendation for Babies

THOMSON REUTERS
·
Dec 06

Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns

Reuters
·
Dec 06

Merck Says the Decision Disregards Decades of Safety and Effectiveness Data That Unequivocally Support Hepatitis B Birth Dose

THOMSON REUTERS
·
Dec 06

Merck, in a Statement, Says It Is Deeply Concerned by Acip’s Vote to Modify the Longstanding Hepatitis B Birth Dose Recommendation

THOMSON REUTERS
·
Dec 06

U.S. advisers scrap hepatitis B vaccine recommendation for most children in major win for Kennedy

Reuters
·
Dec 05

Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating

MT Newswires Live
·
Dec 05

Merck Raises $8 Billion in Multi-Tranche Notes Offering

Reuters
·
Dec 05

Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds

Reuters
·
Dec 05

Merck Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Dec 05

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

Benzinga_recent_news
·
Dec 05

Halozyme Therapeutics Secures Preliminary Injunction Against Merck’s Keytruda SC in Germany Over Patent Infringement

Reuters
·
Dec 05

Halozyme Wins Preliminary Injunction Against Merck's Keytruda Sc in Germany

THOMSON REUTERS
·
Dec 05

Halozyme Therapeutics Inc - Iv Version of Keytruda Remains Available to Patients

THOMSON REUTERS
·
Dec 05